Pubdiz
Taipei Medical University

Pubdiz from Gene to Disease ��] ��Ʈw

A B C D E F G H I J K L M N O P Q R X Y Z



Gene Symbol
Gene NameAliasesPrevious_Symbol

DRD2

dopamine receptor D2


Gene DRD2 gene interaction
View Neighborhood Gene

Result number fewer <<<< << < ALL > >> >>> more

MeSH term
FrequencyCondition_Probility

Female

2010.0

Humans

3170.0

Pregnancy

20.0

Retrospective Studies

30.0

Adult

1390.0

Antipsychotic Agents/therapeutic use

26.0

Comparative Study

470.0

Genotype

1171.0

Male

2130.0

Middle Aged

1220.0

Receptors, Dopamine/*genetics

2739.0

Catechol O-Methyltransferase/*genetics

22.0

Monoamine Oxidase/*genetics

45.0

Mood Disorders/*genetics

425.0

*Polymorphism, Genetic

461.0

Receptor, Serotonin, 5-HT2A

37.0

Receptors, Dopamine D2/*genetics

18550.0

Receptors, Serotonin/*genetics

22.0

Research Support, Non-U.S. Gov't

1920.0

Intelligence/*genetics

426.0

Receptors, Dopamine D2/*genetics/physiology

541.0

Aged

530.0

Antipsychotic Agents/*adverse effects

421.0

DNA/genetics

60.0

Reverse Transcriptase Polymerase Chain Reaction

40.0

Schizophrenic Psychology

25.0

Analysis of Variance

80.0

Australia

31.0

Polymorphism, Genetic/*genetics

352.0

Questionnaires

30.0

Severity of Illness Index

60.0

Asian Continental Ancestry Group/*genetics

51.0

China

40.0

Gene Frequency

400.0

Case-Control Studies

270.0

Obesity/complications/*genetics

337.0

Polymorphism, Restriction Fragment Length

331.0

*Genetic Predisposition to Disease

70.0

Risk Factors

240.0

Smoking/*genetics

819.0

Alleles

1151.0

Bipolar Disorder/*genetics

1412.0

Microsatellite Repeats

30.0

Odds Ratio

90.0

Polymorphism, Genetic

440.0

Adolescent

390.0

Chromatography, High Pressure Liquid

20.0

Genetic Predisposition to Disease

170.0

Genetic Screening

40.0

*Mutation

20.0

Polymerase Chain Reaction

420.0

Research Support, U.S. Gov't, P.H.S.

960.0

Sequence Analysis, DNA

30.0

Variation (Genetics)

110.0

Alcoholism/*genetics

3538.0

Continental Population Groups

31.0

*Membrane Glycoproteins

141.0

Membrane Transport Proteins/*genetics

46.0

Minisatellite Repeats

32.0

*Nerve Tissue Proteins

163.0

Oceanic Ancestry Group/*genetics

28.0

Promoter Regions (Genetics)/*genetics

20.0

Reference Values

110.0

English Abstract

110.0

Gene Expression/genetics

31.0

Gene Frequency/genetics

214.0

Prevalence

80.0

Receptors, Dopamine D2/*genetics/*metabolism

5100.0

Arousal/genetics

250.0

Personality/*genetics

310.0

Personality Inventory

38.0

*Promoter Regions (Genetics)

40.0

Gene Expression/*genetics

87.0

Dopamine Antagonists/therapeutic use

266.0

Exons/*genetics

20.0

Point Mutation/genetics

31.0

Treatment Outcome

60.0

Genetic Markers

150.0

Risk

30.0

Alcoholism/*genetics/rehabilitation

2100.0

Aldehyde Dehydrogenase/*genetics

31.0

*Alleles

231.0

Genetics, Population

71.0

Japan

120.0

Antipsychotic Agents/*therapeutic use

26.0

Clinical Trials

20.0

Genetic Predisposition to Disease/genetics

20.0

Neurotransmitters/*genetics

360.0

Receptors, Dopamine/genetics

650.0

Receptors, Serotonin/genetics

421.0

Schizophrenia/*drug therapy/*genetics

323.0

Homozygote

100.0

Sweden/epidemiology

21.0

Carrier Proteins/*genetics

90.0

Membrane Glycoproteins/genetics

63.0

*Membrane Transport Proteins

162.0

Schizophrenia/*genetics

219.0

Child

230.0

Family

71.0

Linkage Disequilibrium/*genetics

22.0

Mental Disorders/*genetics

315.0

Regression Analysis

50.0

Sex Characteristics

50.0

Comorbidity

72.0

Aged, 80 and over

90.0

DNA Primers

110.0

European Continental Ancestry Group

30.0

Great Britain

20.0

Linkage Disequilibrium

172.0

Migraine/*genetics

215.0

Parkinson Disease/*genetics

56.0

Antipsychotic Agents/blood/*therapeutic use

266.0

Dopamine Antagonists/blood/*therapeutic use

2100.0

Psychiatric Status Rating Scales

104.0

Schizophrenia/*drug therapy

412.0

Taq Polymerase

924.0

Alcohol Dehydrogenase/*genetics

44.0

Membrane Glycoproteins/*genetics

61.0

Mexican Americans/*genetics

312.0

Mutagenesis, Insertional

20.0

Nerve Tissue Proteins/*genetics

30.0

Alcoholism/*genetics/metabolism/psychology

2100.0

DNA/genetics/isolation & purification

20.0

Deoxyribonucleases, Type II Site-Specific/genetics

49.0

Sex Factors

120.0

Alcoholism/genetics

416.0

Behavior, Addictive/*genetics

3100.0

Biological Markers

30.0

Smoking/genetics

210.0

Substance-Related Disorders/genetics

444.0

Gene Expression

30.0

Haplotypes/*genetics

42.0

Polymorphism, Genetic/genetics

111.0

Receptors, Dopamine D2/genetics

1938.0

Alcoholism/*genetics/psychology

660.0

Cross-Sectional Studies

20.0

Taq Polymerase/*genetics

4100.0

Amino Acid Sequence

90.0

Animals

150.0

Molecular Sequence Data

280.0

Gene Deletion

40.0

Haplotypes

180.0

Models, Statistical

21.0

Deoxyribonucleases, Type II Site-Specific/metabolism

42.0

*Methamphetamine

2100.0

*Polymorphism, Restriction Fragment Length

111.0

Substance-Related Disorders/*genetics

531.0

Heterozygote

50.0

Indians, North American/genetics

25.0

Dopamine/metabolism

43.0

Intelligence Tests

23.0

Phenotype

200.0

Alcoholism/epidemiology/*genetics

330.0

Receptors, GABA-A/*genetics

56.0

Social Environment

211.0

Variation (Genetics)/*genetics

52.0

Carrier Proteins/genetics

71.0

Italy

50.0

Promoter Regions (Genetics)

50.0

Alcoholism/*complications/*genetics

266.0

Deoxyribonucleases, Type II Site-Specific

62.0

Schizophrenia/drug therapy/*genetics

318.0

Exploratory Behavior

222.0

Apolipoproteins E/*genetics

20.0

Statistics, Nonparametric

30.0

Recurrence/prevention & control

25.0

Alcoholism/*genetics/physiopathology

266.0

Event-Related Potentials, P300/*genetics

2100.0

Family Health

40.0

Linkage (Genetics)

250.0

Lod Score

80.0

Environment

22.0

Personality/genetics

228.0

Chi-Square Distribution

162.0

Chromosomes, Human, Pair 11/*genetics

41.0

*Genetics, Population

20.0

Body Mass Index

60.0

Indians, North American/*genetics

22.0

Longitudinal Studies

30.0

Obesity/*genetics

32.0

Dopamine/physiology

23.0

Dopamine beta-Hydroxylase/*genetics

36.0

Cloning, Molecular

60.0

Dose-Response Relationship, Drug

30.0

Pedigree

190.0

Phylogeny

20.0

Sequence Alignment

20.0

Sequence Homology, Amino Acid

20.0

Tissue Distribution

20.0

African Continental Ancestry Group/*genetics

20.0

Risk Assessment

30.0

*Heterozygote

41.0

Models, Genetic

160.0

Introns/genetics

40.0

Polymerase Chain Reaction/methods

40.0

Catechol O-Methyltransferase/genetics

310.0

Isoenzymes/genetics

20.0

Reproducibility of Results

20.0

Age of Onset

80.0

Child, Preschool

50.0

Cytoskeletal Proteins/*genetics

21.0

DNA Mutational Analysis

80.0

Myoclonus/*genetics

333.0

Sarcoglycans

28.0

*Variation (Genetics)

70.0

Sequence Deletion

20.0

Alcoholism/diagnosis/*genetics

240.0

Genetic Predisposition to Disease/*genetics

41.0

Amino Acid Substitution

20.0

Bipolar Disorder/genetics

29.0

Cysteine

65.0

Depressive Disorder/genetics

323.0

Psychotic Disorders/*genetics/psychology

250.0

Schizophrenia/genetics

415.0

Serine

66.0

Brain/metabolism

20.0

Obesity/genetics

23.0

Receptors, Dopamine D2/*genetics/metabolism

450.0

Membrane Transport Proteins/genetics

412.0

Nerve Tissue Proteins/genetics

51.0

Dopamine/genetics

240.0

Serotonin/genetics

225.0

*Chromosome Mapping

40.0

Mice

40.0

Mice, Inbred C57BL

20.0

Research Support, U.S. Gov't, Non-P.H.S.

210.0

Attention Deficit Disorder with Hyperactivity/genetics

228.0

*Linkage Disequilibrium

74.0

*Logistic Models

222.0

Statistics

30.0

Body Height/*genetics

27.0

Cholesterol/blood

20.0

Nuclear Family

20.0

Promoter Regions (Genetics)/genetics

20.0

DNA/analysis

60.0

Dystonia/*genetics

313.0

Linkage (Genetics)/genetics

51.0

Chromosome Mapping

300.0

Follow-Up Studies

20.0

Linkage Disequilibrium/genetics

42.0

Prospective Studies

50.0

Age Factors

60.0

*Linkage (Genetics)

131.0

African Continental Ancestry Group/genetics

41.0

European Continental Ancestry Group/genetics

111.0

Smoking/epidemiology/*genetics

240.0

Attention Deficit Disorder with Hyperactivity/*genetics

36.0

Brain Chemistry/genetics

24.0

*Family Health

23.0

Dopamine/*genetics

538.0

Dopamine beta-Hydroxylase/genetics

27.0

Spain/epidemiology

21.0

Blotting, Southern

50.0

Cells, Cultured

30.0

Hybrid Cells/cytology

26.0

In Situ Hybridization, Fluorescence

30.0

Karyotyping

20.0

Parents

22.0

European Continental Ancestry Group/*genetics

82.0

Repetitive Sequences, Nucleic Acid/genetics

55.0

Double-Blind Method

30.0

Placebos

20.0

Introns

40.0

Tomography, Emission-Computed

21.0

Autistic Disorder/genetics

214.0

*Chromosomes, Human, Pair 11

213.0

Base Sequence

240.0

Corpus Striatum/*metabolism

210.0

*DNA Methylation

20.0

Lymphocytes/metabolism

20.0

*Gene Frequency

30.0

Taiwan/epidemiology

21.0

*Mutation, Missense

20.0

Binding, Competitive

20.0

Hamsters

20.0

China/ethnology

21.0

Data Collection

22.0

Ethnic Groups/genetics

21.0

Receptors, Dopamine D1/*genetics

27.0

Gene Dosage

20.0

DNA Primers/genetics

20.0

Evolution

20.0

*Genome, Human

20.0

Europe/ethnology

22.0

Asian Continental Ancestry Group/genetics

20.0

*Chromosome Deletion

20.0

Behavior, Addictive/genetics

250.0

Polymorphism, Single Nucleotide

20.0

Mutation

70.0

Dopamine/*physiology

33.0

Reward

514.0

*Schizophrenic Psychology

34.0

Bupropion/*therapeutic use

2100.0

Smoking Cessation/ethnology/*methods

2100.0

Twin Studies

211.0

gamma-Aminobutyric Acid/*physiology

213.0

Restriction Mapping

50.0

Glycine/genetics

22.0

Serine/genetics

22.0

Deoxyribonucleases, Type II Site-Specific/*genetics

412.0

Genome

20.0

Exons

100.0

Tourette Syndrome/*genetics

317.0

Gene Expression Regulation

20.0

Receptors, Dopamine D2/*genetics/*physiology

2100.0

Quebec

23.0

Haplotypes/genetics

40.0

Taiwan

31.0

*Haplotypes

52.0

Child of Impaired Parents/*psychology

250.0

Event-Related Potentials, P300/genetics

266.0

Orientation

240.0

Psychomotor Performance

26.0

Dopamine/*metabolism

21.0

Tyrosine 3-Monooxygenase/*genetics

53.0

Mental Disorders/genetics

214.0

Cell Line

20.0

Spiperone/analogs & derivatives/metabolism

2100.0

*Cocaine

233.0

Genetic Markers/*genetics

32.0

Substance-Related Disorders/*genetics/psychology

266.0

DNA-Directed DNA Polymerase

27.0

Recurrence

20.0

Alcoholism/genetics/psychology

266.0

Heterozygote Detection

40.0

United States

20.0

Schizophrenia/epidemiology/*genetics

29.0

Diagnostic and Statistical Manual of Mental Disorders

28.0

Schizophrenia/diagnosis/*genetics

320.0

Alcoholism/ethnology/*genetics

222.0

Alcoholism/diagnosis/*genetics/rehabilitation

2100.0

*Gene Deletion

20.0

Linkage (Genetics)/*genetics

62.0

Serotonin/*genetics

222.0

*Genotype

20.0

DNA

30.0

Sequence Analysis

20.0

Genetic Markers/genetics

71.0

*Psychotropic Drugs

375.0

*Street Drugs

375.0

Chromosomes, Human, Pair 1

20.0

Neuropsychological Tests

20.0

Cell Adhesion Molecules, Neuronal/*genetics

27.0

Genes, Structural

30.0

Substance-Related Disorders/genetics/physiopathology

266.0

*Point Mutation

30.0

DNA-Directed DNA Polymerase/*genetics

27.0

Nucleic Acid Hybridization

40.0

Internal-External Control

218.0

Chromosomes, Human, Pair 11

20.0

Tourette Syndrome/diagnosis/*genetics

266.0

Substance-Related Disorders/*genetics/rehabilitation

2100.0

France

20.0

Ataxia Telangiectasia/*genetics

34.0

African Continental Ancestry Group

20.0

Genome, Human

20.0

Genetic Predisposition to Disease/epidemiology

22.0

Receptors, Dopamine D2

960.0

Mutation/genetics

20.0

Oligodeoxyribonucleotides/genetics

22.0

DNA/isolation & purification

21.0

Schizophrenia/drug therapy/genetics

250.0

Italy/epidemiology

20.0

Receptors, Muscarinic/*immunology

2100.0

Protein Biosynthesis

20.0

Antipsychotic Agents/*adverse effects/therapeutic use

216.0

Dyskinesia, Drug-Induced/etiology/*genetics

266.0

Neuroleptic Malignant Syndrome/*genetics

266.0